Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

SELL
$53.86 - $66.8 $2.52 Million - $3.12 Million
-46,699 Reduced 99.4%
283 $16,000
Q2 2022

Aug 10, 2022

BUY
$63.83 - $80.0 $177,255 - $222,160
2,777 Added 6.28%
46,982 $3.02 Million
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $81,307 - $94,638
-1,058 Reduced 2.34%
44,205 $3.43 Million
Q4 2021

Feb 10, 2022

BUY
$74.57 - $87.19 $3.38 Million - $3.95 Million
45,263 New
45,263 $3.89 Million
Q1 2020

May 13, 2020

SELL
$71.57 - $93.3 $4.98 Million - $6.49 Million
-69,559 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$81.4 - $89.78 $1.03 Million - $1.14 Million
12,705 Added 22.35%
69,559 $6.08 Million
Q2 2019

Aug 06, 2019

BUY
$73.44 - $82.41 $223,110 - $250,361
3,038 Added 5.65%
56,854 $4.66 Million
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $488,242 - $615,679
-7,572 Reduced 12.33%
53,816 $4.38 Million
Q4 2018

Feb 14, 2019

SELL
$61.45 - $77.8 $5.47 Million - $6.93 Million
-89,072 Reduced 59.2%
61,388 $4.04 Million
Q3 2018

Nov 06, 2018

SELL
$70.71 - $77.75 $1.56 Million - $1.72 Million
-22,103 Reduced 12.81%
150,460 $11.6 Million
Q2 2018

Jul 27, 2018

SELL
$63.43 - $75.41 $1.89 Million - $2.24 Million
-29,734 Reduced 14.7%
172,563 $12.7 Million
Q1 2018

May 15, 2018

SELL
$62.56 - $72.26 $962,485 - $1.11 Million
-15,385 Reduced 7.07%
202,297 $13.2 Million
Q4 2017

Feb 12, 2018

BUY
$61.45 - $66.05 $5.88 Million - $6.32 Million
95,649 Added 78.38%
217,682 $14.1 Million
Q3 2017

Nov 09, 2017

BUY
$59.5 - $64.61 $1.65 Million - $1.79 Million
27,751 Added 29.43%
122,033 $7.66 Million
Q2 2017

Aug 29, 2017

BUY
N/A
94,282
94,282 $5.71 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Achmea Investment Management B.V. Portfolio

Follow Achmea Investment Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.